MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Microarray analysis upon an synthetic α-synuclein induced model reveals some susceptibility genes in Parkinson’s disease

E. Tao (Guangzhou, China)

Meeting: 2018 International Congress

Abstract Number: 1347

Keywords: Alpha-synuclein

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Genetics

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To uncover new disease-associated genes and their relevant mechanisms in the pathogenetic process of neurodegenerative disorders, we carried out a gene microarray analysis based on a Parkinson’s disease (PD) in vitro model induced by α-synuclein oligomers.

Background: The gene microarray was performed upon the cellular model induced by 25 mol/L α-synuclein oligomers, which has been confirmed to show the stable, transmissible neurotoxicity of α-synuclein, a typical PD pathological marker. And the different expressed long non-coding RNA(lncRNA) was screened out for the reseach of its potential influence upon the pathogenetic process of neurodegenerative disorders.

Methods: Immumofluorescence and electron microscope were used to make sure α-synuclein have already entered the cells and led to α-synuclein lesions. The expression of lncRNAs and mRNAs is analyzed by gene microarray and GeneSpring GX v12.1 software package. Differently-expressed genes(DEGs) were verified by real time qPCR and the selected genes were studied by ceRNA(competing endogenous RNAs) analysis.

Results: A significant differentially expressed lncRNAs, G069488, were chosen as a breakthrough point for the further research because it was located to the gene NEED9, which is relative to the axon growth and neurodevelopment closely. Subsequent verified qPCR experiment determined the same variation trend as the result of microarray analysis showed.

Conclusions: The results of the present study widen our horizon of PD susceptibility genes and provide new pathways towards efficient diagnostic biomarkers and therapeutic targets for PD.

To cite this abstract in AMA style:

E. Tao. Microarray analysis upon an synthetic α-synuclein induced model reveals some susceptibility genes in Parkinson’s disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/microarray-analysis-upon-an-synthetic-%ce%b1-synuclein-induced-model-reveals-some-susceptibility-genes-in-parkinsons-disease/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/microarray-analysis-upon-an-synthetic-%ce%b1-synuclein-induced-model-reveals-some-susceptibility-genes-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley